Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Short Interest Update

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totalling 1,581,500 shares, a decrease of 9.2% from the July 15th total of 1,740,800 shares. Based on an average trading volume of 1,104,200 shares, the short-interest ratio is currently 1.4 days.

Elite Pharmaceuticals Price Performance

ELTP opened at $0.20 on Tuesday. The stock’s 50 day moving average price is $0.18 and its 200 day moving average price is $0.16. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.94 and a quick ratio of 1.19. The stock has a market cap of $212.59 million, a P/E ratio of 19.90 and a beta of 0.11. Elite Pharmaceuticals has a 12 month low of $0.06 and a 12 month high of $0.21.

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.